4.7 Article

Improved outcomes in pediatric epilepsy surgery The UCLA experience, 1986-2008

Journal

NEUROLOGY
Volume 74, Issue 22, Pages 1768-1775

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0b013e3181e0f17a

Keywords

-

Funding

  1. NIH [R01 NS38992]
  2. CAPES [2503-08-5]
  3. CNPq [201031/2008-6]
  4. Dalyit S. and Flaine Sarkaria Chair in Diagnostic Medicine
  5. Brazilian government (CAPES) [2503-08-5]
  6. Brazilian government (CNPq) [201031/2008-6]
  7. Novartis
  8. NIH/NINDS [K23 NS051637, NS046516, NS045911, NS059505, MH079933, RO1 NS 38992]
  9. Thrasher Research Fund
  10. Lundbeck Inc.
  11. Ortho-McNeil-Janssen Pharmaceuticals, Inc.
  12. NeuroTherapeutics Pharma, Inc.
  13. Valeant Pharmaceuticals International
  14. Marinus Pharmaceuticals, Inc.
  15. Epilepsy Foundation of America
  16. American Society of Neuroradiology Research Foundation

Ask authors/readers for more resources

Objective: Epilepsy neurosurgery is a treatment option for children with refractory epilepsy. Our aim was to determine if outcomes improved over time. Methods: Pediatric epilepsy surgery patients operated in the first 11 years (1986-1997; pre-1997) were compared with the second 11 years (1998-2008; post-1997) for differences in presurgical and postsurgical variables. Results: Despite similarities in seizure frequency, age at seizure onset, and age at surgery, the post-1997 series had more lobar/focal and fewer multilobar resections, and more patients with tuberous sclerosis complex and fewer cases of nonspecific gliosis compared with the pre-1997 group. Fewer cases had intracranial EEG studies in the post-1997 (0.8%) compared with the pre-1997 group (9%). Compared with the pre-1997 group, the post-1997 series had more seizure-free patients at 0.5 (83%, +16%), 1 (81%, +18%), 2 (77%, +19%), and 5 (74%, +29%) years, and more seizure-free patients were on medications at 0.5 (97%, +6%), 1 (88%, +9%), and 2 (76%, +29%), but not 5 (64%, +8%) years after surgery. There were fewer complications and reoperations in the post-1997 series compared with the pre-1997 group. Logistic regression identified post-1997 series and less aggressive medication withdrawal as the main predictors of becoming seizure-free 2 years after surgery. Conclusions: Improved technology and surgical procedures along with changes in clinical practice were likely factors linked with enhanced and sustained seizure-free outcomes in the post-1997 series. These findings support the general concept that clearer identification of lesions and complete resection are linked with better outcomes in pediatric epilepsy surgery patients. Neurology(R) 2010;74:1768-1775

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available